Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy
Applied Biochemistry and Biotechnology · 2026-07 · 198 (7) · 5212-5230
DOI: 10.1007/s12010-026-05702-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 15.04.2026. Verfasst von Sandeep und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, In…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Tumor Necrosis Factor-alpha, Interleukin-23, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Science and Engineering Research Board (SERB), National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India. apande@niper.ac.in.
Förderung
- Science and Engineering Research Board (SERB)
- National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar
- Indian Council of Medical Research
- Department of Biotechnology
Zitieren
APA
Sandeep, Shinde, S. H., Ahmed, S., Sharma, S. S., & Pande, A. H. (2026). Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy. Applied Biochemistry and Biotechnology, 198(7), 5212-5230. https://doi.org/10.1007/s12010-026-05702-0
Vancouver
Sandeep, Shinde SH, Ahmed S, Sharma SS, Pande AH. Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy. Applied Biochemistry and Biotechnology. 2026;198(7):5212-5230. doi:10.1007/s12010-026-05702-0
BibTeX
@article{Sandeep2026,
author = {Sandeep and Shinde, Suraj H and Ahmed, Sakeel and Sharma, Shyam Sunder and Pande, Abhay H},
title = {Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy},
journal = {Applied Biochemistry and Biotechnology},
year = {2026},
volume = {198},
number = {7},
pages = {5212--5230},
doi = {10.1007/s12010-026-05702-0}
}
EUVIMED